CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

Biotech stocks may be one of the big winners if the Federal Reserve is almost finished raising interest rates. CRISPR Therapeutics is at the forefront of gene editing, which may be ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.